Patient Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB, which includes delamanid and bedaquiline. Khayelitsha, Western Cape.
All Topics

Drug-resistant TB

 
Simphiwe holds his medication, he takes up to 26 pills a day to treat XDR-TB. Here he holds his morning selection, which includes delamanid, one of the newest DR-TB drugs, which Simphiwe is taking for the first time today.
Drug-resistant TB

MSF response: WHO announces positive change to TB treatment guidelines

Press Release 4 May 2022
 
TB diagnosis in Tajikstan
Tuberculosis

MSF responds to updated WHO guidelines for tuberculosis in children

Press Release 25 Mar 2022
 
Sinethemba takes her daily regimen for XDR-TB at 10am each day, with two additional delamanid tablets at night.
South Africa

Khayelitsha: MSF family-centred TB approach informs new WHO guidance on caring for children with drug-resistant TB

Press Release 24 Mar 2022
 
National Reference Laboratory, Abovyan. Sputum culture is currently used to detect TB, together with chest X-rays, sputum smear microscopy and Mantoux test
Drug-resistant TB

Lifesaving TB medicines must be affordable and available to make all-oral treatments for children a reality

Latest News 6 Sep 2021
 
COVID-19 (coronavirus disease)

J&J price reduction on key DR-TB drug important, governments should scale up treatment urgently

Press Release 6 Jul 2020
 
COVID-19 (coronavirus disease)

Knock-on effects of the COVID-19 pandemic: adapting MSF projects to continue essential medical care

Latest News 25 May 2020